 Girish Shirali
Concepts (359)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 35 | 2020 | 81 | 6.780 |
Why?
| | Echocardiography | 37 | 2022 | 93 | 5.300 |
Why?
| | Echocardiography, Three-Dimensional | 24 | 2018 | 26 | 4.820 |
Why?
| | Heart Ventricles | 22 | 2023 | 55 | 4.150 |
Why?
| | Ventricular Dysfunction, Left | 12 | 2017 | 18 | 2.240 |
Why?
| | Pulmonary Valve Insufficiency | 7 | 2023 | 7 | 2.120 |
Why?
| | Cardiac Catheterization | 16 | 2023 | 24 | 2.120 |
Why?
| | Humans | 104 | 2023 | 6929 | 2.060 |
Why?
| | Ventricular Function, Left | 13 | 2019 | 30 | 1.680 |
Why?
| | Pulmonary Valve | 7 | 2023 | 7 | 1.670 |
Why?
| | Fontan Procedure | 9 | 2022 | 19 | 1.620 |
Why?
| | Cardiac Surgical Procedures | 13 | 2016 | 34 | 1.580 |
Why?
| | Heart Transplantation | 10 | 2017 | 17 | 1.580 |
Why?
| | Pediatrics | 9 | 2016 | 183 | 1.520 |
Why?
| | Infant | 40 | 2023 | 1449 | 1.480 |
Why?
| | Heart Failure | 5 | 2022 | 14 | 1.460 |
Why?
| | Heart Valve Prosthesis Implantation | 7 | 2023 | 7 | 1.430 |
Why?
| | Female | 54 | 2021 | 3534 | 1.400 |
Why?
| | Male | 48 | 2021 | 3367 | 1.310 |
Why?
| | Echocardiography, Doppler, Color | 5 | 2016 | 6 | 1.300 |
Why?
| | Heart Valve Prosthesis | 6 | 2023 | 7 | 1.250 |
Why?
| | Image Interpretation, Computer-Assisted | 6 | 2018 | 22 | 1.200 |
Why?
| | Aortic Rupture | 2 | 2016 | 2 | 1.160 |
Why?
| | Practice Guidelines as Topic | 3 | 2016 | 104 | 1.150 |
Why?
| | Aorta, Thoracic | 5 | 2016 | 9 | 1.120 |
Why?
| | Stroke Volume | 12 | 2018 | 20 | 1.090 |
Why?
| | Child, Preschool | 36 | 2018 | 1562 | 1.080 |
Why?
| | Child | 44 | 2022 | 3348 | 1.060 |
Why?
| | Infant, Newborn | 29 | 2021 | 826 | 1.040 |
Why?
| | Adolescent | 38 | 2022 | 2183 | 1.020 |
Why?
| | Heart Diseases | 7 | 2022 | 19 | 0.990 |
Why?
| | Heart Septal Defects, Atrial | 4 | 2006 | 7 | 0.980 |
Why?
| | Hypoplastic Left Heart Syndrome | 9 | 2020 | 21 | 0.980 |
Why?
| | Adult | 20 | 2023 | 1199 | 0.950 |
Why?
| | Treatment Outcome | 20 | 2023 | 649 | 0.940 |
Why?
| | Cardiomyopathies | 3 | 2015 | 6 | 0.870 |
Why?
| | Aortic Coarctation | 3 | 2016 | 6 | 0.810 |
Why?
| | Echocardiography, Transesophageal | 6 | 2012 | 10 | 0.800 |
Why?
| | Reproducibility of Results | 18 | 2021 | 198 | 0.790 |
Why?
| | Heart | 4 | 2016 | 16 | 0.760 |
Why?
| | Ventricular Function, Right | 3 | 2016 | 17 | 0.750 |
Why?
| | Image Enhancement | 3 | 2016 | 14 | 0.740 |
Why?
| | Pulmonary Artery | 8 | 2013 | 10 | 0.730 |
Why?
| | Ultrasonography, Prenatal | 5 | 2015 | 11 | 0.730 |
Why?
| | Cardiac Imaging Techniques | 2 | 2016 | 2 | 0.710 |
Why?
| | Cardiology | 7 | 2015 | 11 | 0.690 |
Why?
| | Aortic Stenosis, Supravalvular | 2 | 2016 | 2 | 0.650 |
Why?
| | Exercise | 2 | 2020 | 132 | 0.630 |
Why?
| | Sensitivity and Specificity | 12 | 2016 | 151 | 0.610 |
Why?
| | Follow-Up Studies | 17 | 2019 | 329 | 0.610 |
Why?
| | Prospective Studies | 16 | 2023 | 547 | 0.600 |
Why?
| | Patient Care Team | 2 | 2020 | 18 | 0.600 |
Why?
| | United States | 14 | 2020 | 670 | 0.590 |
Why?
| | Aortic Aneurysm | 1 | 2016 | 1 | 0.580 |
Why?
| | Sinus of Valsalva | 1 | 2016 | 2 | 0.580 |
Why?
| | Cardiology Service, Hospital | 1 | 2016 | 3 | 0.560 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2016 | 7 | 0.560 |
Why?
| | Heart Septal Defects, Ventricular | 4 | 2011 | 6 | 0.520 |
Why?
| | Telemedicine | 1 | 2016 | 59 | 0.500 |
Why?
| | Young Adult | 11 | 2022 | 641 | 0.480 |
Why?
| | Prognosis | 8 | 2021 | 216 | 0.470 |
Why?
| | Cardiomyopathy, Dilated | 4 | 2015 | 9 | 0.460 |
Why?
| | Magnetic Resonance Imaging | 6 | 2016 | 122 | 0.450 |
Why?
| | Echocardiography, Doppler | 7 | 2019 | 13 | 0.450 |
Why?
| | Retrospective Studies | 14 | 2023 | 1337 | 0.440 |
Why?
| | Risk Factors | 14 | 2023 | 490 | 0.440 |
Why?
| | Palliative Care | 4 | 2020 | 17 | 0.430 |
Why?
| | Societies, Medical | 4 | 2016 | 50 | 0.420 |
Why?
| | Fetal Diseases | 2 | 2004 | 5 | 0.410 |
Why?
| | Aortic Diseases | 2 | 2013 | 4 | 0.400 |
Why?
| | Postoperative Complications | 6 | 2018 | 202 | 0.400 |
Why?
| | Ventricular Pressure | 3 | 2019 | 4 | 0.390 |
Why?
| | Graft Rejection | 4 | 2015 | 32 | 0.380 |
Why?
| | Monitoring, Physiologic | 3 | 2020 | 23 | 0.380 |
Why?
| | Diastole | 7 | 2019 | 12 | 0.370 |
Why?
| | Predictive Value of Tests | 5 | 2021 | 102 | 0.370 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 9 | 0.360 |
Why?
| | Feasibility Studies | 7 | 2020 | 59 | 0.360 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2009 | 4 | 0.350 |
Why?
| | Vascular Malformations | 1 | 2009 | 3 | 0.350 |
Why?
| | Angiography | 1 | 2009 | 10 | 0.350 |
Why?
| | Time Factors | 7 | 2023 | 263 | 0.350 |
Why?
| | Europe | 5 | 2016 | 40 | 0.350 |
Why?
| | Ventricular Function | 2 | 2022 | 6 | 0.320 |
Why?
| | Ventricular Fibrillation | 1 | 2007 | 1 | 0.310 |
Why?
| | Ventricular Outflow Obstruction | 3 | 2018 | 3 | 0.300 |
Why?
| | Transposition of Great Vessels | 3 | 2011 | 8 | 0.280 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 11 | 0.280 |
Why?
| | Abnormalities, Multiple | 2 | 2008 | 36 | 0.280 |
Why?
| | Balloon Occlusion | 1 | 2005 | 1 | 0.270 |
Why?
| | Norwood Procedures | 3 | 2020 | 5 | 0.270 |
Why?
| | Systole | 4 | 2015 | 13 | 0.260 |
Why?
| | Stroke | 1 | 2005 | 22 | 0.260 |
Why?
| | Heart Atria | 2 | 2005 | 5 | 0.260 |
Why?
| | Prosthesis Design | 4 | 2023 | 14 | 0.250 |
Why?
| | Internship and Residency | 2 | 2015 | 36 | 0.250 |
Why?
| | Survival Rate | 5 | 2007 | 83 | 0.250 |
Why?
| | Myocardium | 2 | 2015 | 9 | 0.240 |
Why?
| | Oxygen Consumption | 2 | 2022 | 18 | 0.240 |
Why?
| | Equipment Failure Analysis | 2 | 2014 | 4 | 0.230 |
Why?
| | Radiology, Interventional | 1 | 2003 | 1 | 0.230 |
Why?
| | Equipment Design | 4 | 2014 | 14 | 0.230 |
Why?
| | Ultrasonography | 4 | 2013 | 49 | 0.230 |
Why?
| | Algorithms | 3 | 2015 | 108 | 0.230 |
Why?
| | Myocardial Contraction | 3 | 2018 | 13 | 0.210 |
Why?
| | Embolization, Therapeutic | 1 | 2002 | 15 | 0.210 |
Why?
| | Pregnancy | 6 | 2009 | 212 | 0.210 |
Why?
| | Cardiovascular Diseases | 2 | 2013 | 49 | 0.200 |
Why?
| | Oxygen | 2 | 2020 | 13 | 0.200 |
Why?
| | Coronary Artery Disease | 3 | 2011 | 10 | 0.200 |
Why?
| | Telemetry | 1 | 2021 | 2 | 0.200 |
Why?
| | Remote Consultation | 1 | 2021 | 4 | 0.200 |
Why?
| | Patient Admission | 1 | 2021 | 10 | 0.200 |
Why?
| | Adenoviridae Infections | 1 | 2001 | 1 | 0.200 |
Why?
| | Genome, Viral | 1 | 2001 | 4 | 0.200 |
Why?
| | Video Recording | 1 | 2021 | 15 | 0.200 |
Why?
| | Adenoviridae | 1 | 2001 | 6 | 0.200 |
Why?
| | Aortic Valve | 3 | 2016 | 4 | 0.200 |
Why?
| | Observer Variation | 5 | 2016 | 14 | 0.200 |
Why?
| | Coronary Vessels | 2 | 2011 | 9 | 0.190 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2011 | 9 | 0.190 |
Why?
| | Ductus Arteriosus, Patent | 2 | 2006 | 4 | 0.190 |
Why?
| | Heart Aneurysm | 1 | 2000 | 1 | 0.190 |
Why?
| | Home Nursing | 1 | 2020 | 2 | 0.190 |
Why?
| | Middle Aged | 4 | 2009 | 645 | 0.180 |
Why?
| | Weight Gain | 1 | 2020 | 23 | 0.180 |
Why?
| | Quality Improvement | 2 | 2020 | 60 | 0.180 |
Why?
| | Caregivers | 2 | 2020 | 38 | 0.180 |
Why?
| | Enteral Nutrition | 1 | 2020 | 65 | 0.180 |
Why?
| | Enalapril | 1 | 2019 | 1 | 0.180 |
Why?
| | Recovery of Function | 2 | 2018 | 22 | 0.170 |
Why?
| | Dilatation, Pathologic | 2 | 2016 | 6 | 0.170 |
Why?
| | Mitral Valve | 3 | 2007 | 5 | 0.160 |
Why?
| | Marfan Syndrome | 2 | 2013 | 2 | 0.160 |
Why?
| | Incidence | 6 | 2016 | 134 | 0.160 |
Why?
| | Home Care Services | 1 | 2018 | 6 | 0.160 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 18 | 0.160 |
Why?
| | Medical Records | 1 | 2018 | 13 | 0.160 |
Why?
| | Pulmonary Veins | 1 | 1998 | 1 | 0.160 |
Why?
| | Cross-Over Studies | 1 | 2018 | 35 | 0.160 |
Why?
| | Transplant Recipients | 1 | 2017 | 9 | 0.160 |
Why?
| | Exercise Test | 2 | 2015 | 18 | 0.150 |
Why?
| | Expert Testimony | 1 | 2016 | 3 | 0.140 |
Why?
| | Vascular Stiffness | 1 | 2016 | 5 | 0.140 |
Why?
| | Patient Care Bundles | 1 | 2016 | 3 | 0.140 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 45 | 0.140 |
Why?
| | Consensus | 1 | 2016 | 33 | 0.140 |
Why?
| | Postoperative Care | 1 | 2016 | 29 | 0.140 |
Why?
| | Remote Sensing Technology | 1 | 2016 | 3 | 0.140 |
Why?
| | Cloud Computing | 1 | 2016 | 4 | 0.140 |
Why?
| | Anastomosis, Surgical | 4 | 2012 | 22 | 0.140 |
Why?
| | Diffusion of Innovation | 1 | 2016 | 7 | 0.140 |
Why?
| | Models, Organizational | 1 | 2016 | 7 | 0.140 |
Why?
| | Attitude to Computers | 1 | 2016 | 4 | 0.140 |
Why?
| | Computers, Handheld | 1 | 2016 | 8 | 0.140 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 14 | 0.140 |
Why?
| | Program Evaluation | 1 | 2016 | 45 | 0.140 |
Why?
| | Clinical Competence | 3 | 2015 | 30 | 0.130 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 6 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 63 | 0.130 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 6 | 0.130 |
Why?
| | Multivariate Analysis | 4 | 2009 | 73 | 0.130 |
Why?
| | Aged | 3 | 2009 | 411 | 0.130 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2015 | 1 | 0.130 |
Why?
| | Advisory Committees | 1 | 2015 | 9 | 0.130 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2016 | 3 | 0.130 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 16 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 16 | 0.130 |
Why?
| | Biomarkers | 2 | 2016 | 132 | 0.130 |
Why?
| | Internationality | 1 | 2014 | 6 | 0.120 |
Why?
| | Elasticity Imaging Techniques | 1 | 2014 | 7 | 0.120 |
Why?
| | Neoplasms | 1 | 2016 | 126 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2020 | 216 | 0.120 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2014 | 6 | 0.120 |
Why?
| | Thinness | 1 | 2014 | 8 | 0.120 |
Why?
| | Ultrasonography, Interventional | 2 | 2013 | 3 | 0.120 |
Why?
| | Severity of Illness Index | 3 | 2015 | 148 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2005 | 168 | 0.120 |
Why?
| | Biopsy | 2 | 2006 | 63 | 0.110 |
Why?
| | Ultrasonic Therapy | 1 | 2013 | 1 | 0.110 |
Why?
| | Cardiac Catheters | 1 | 2013 | 1 | 0.110 |
Why?
| | Body Mass Index | 1 | 2014 | 156 | 0.110 |
Why?
| | Obesity | 1 | 2014 | 124 | 0.110 |
Why?
| | Organ Size | 4 | 2012 | 14 | 0.110 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 78 | 0.110 |
Why?
| | South Carolina | 3 | 2014 | 3 | 0.100 |
Why?
| | Data Display | 1 | 2012 | 1 | 0.100 |
Why?
| | Heart Valves | 1 | 2012 | 1 | 0.100 |
Why?
| | Bioprosthesis | 1 | 2011 | 1 | 0.100 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2011 | 1 | 0.100 |
Why?
| | Risk Assessment | 3 | 2021 | 136 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 35 | 0.100 |
Why?
| | Mitral Valve Insufficiency | 1 | 2011 | 1 | 0.100 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2011 | 4 | 0.100 |
Why?
| | Exercise Tolerance | 1 | 2010 | 8 | 0.100 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 333 | 0.090 |
Why?
| | Miniaturization | 1 | 2010 | 2 | 0.090 |
Why?
| | Treatment Failure | 2 | 2011 | 17 | 0.090 |
Why?
| | Quality of Life | 2 | 2022 | 139 | 0.090 |
Why?
| | Coronary Disease | 2 | 2001 | 10 | 0.090 |
Why?
| | Septal Occluder Device | 1 | 2009 | 3 | 0.090 |
Why?
| | Radiation Dosage | 1 | 2009 | 5 | 0.090 |
Why?
| | Stents | 1 | 2009 | 15 | 0.090 |
Why?
| | Chromosome Aberrations | 1 | 2009 | 12 | 0.090 |
Why?
| | Vitamin A | 1 | 1989 | 3 | 0.090 |
Why?
| | Cardiac Volume | 1 | 2009 | 1 | 0.090 |
Why?
| | Decision Making | 1 | 2009 | 23 | 0.090 |
Why?
| | Heart Septum | 2 | 2006 | 6 | 0.090 |
Why?
| | Intensive Care Units | 1 | 2009 | 18 | 0.080 |
Why?
| | Heart Valve Diseases | 2 | 2007 | 2 | 0.080 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2008 | 3 | 0.080 |
Why?
| | Mass Screening | 1 | 2008 | 34 | 0.080 |
Why?
| | Reoperation | 3 | 2020 | 64 | 0.080 |
Why?
| | Comorbidity | 3 | 2014 | 56 | 0.080 |
Why?
| | Disease Progression | 2 | 2021 | 110 | 0.080 |
Why?
| | Parents | 1 | 2009 | 152 | 0.080 |
Why?
| | Statistics as Topic | 1 | 2007 | 19 | 0.080 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2007 | 1 | 0.080 |
Why?
| | Heart Bypass, Right | 1 | 2007 | 3 | 0.080 |
Why?
| | Prenatal Diagnosis | 2 | 2005 | 14 | 0.080 |
Why?
| | Preoperative Care | 1 | 2007 | 28 | 0.070 |
Why?
| | Communication | 2 | 2020 | 45 | 0.070 |
Why?
| | Heart Septal Defects | 1 | 2006 | 1 | 0.070 |
Why?
| | Research Design | 1 | 2006 | 63 | 0.070 |
Why?
| | Pilot Projects | 2 | 2017 | 114 | 0.070 |
Why?
| | Heart Arrest | 1 | 2006 | 2 | 0.070 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2006 | 2 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 85 | 0.070 |
Why?
| | Regression Analysis | 2 | 2015 | 52 | 0.070 |
Why?
| | Medical Illustration | 1 | 2004 | 1 | 0.060 |
Why?
| | Congresses as Topic | 2 | 2015 | 9 | 0.060 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2004 | 3 | 0.060 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2004 | 3 | 0.060 |
Why?
| | Trisomy | 1 | 2004 | 2 | 0.060 |
Why?
| | Pregnancy Outcome | 1 | 2004 | 8 | 0.060 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 53 | 0.060 |
Why?
| | Empathy | 1 | 2023 | 2 | 0.060 |
Why?
| | Hand Strength | 1 | 2022 | 7 | 0.050 |
Why?
| | Fatigue | 1 | 2022 | 15 | 0.050 |
Why?
| | Prevalence | 2 | 2014 | 150 | 0.050 |
Why?
| | Equipment Safety | 1 | 2002 | 1 | 0.050 |
Why?
| | Device Removal | 1 | 2002 | 18 | 0.050 |
Why?
| | Pulmonary Circulation | 1 | 2002 | 1 | 0.050 |
Why?
| | Patient Selection | 1 | 2002 | 34 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2002 | 21 | 0.050 |
Why?
| | Pulmonary Atresia | 1 | 2001 | 1 | 0.050 |
Why?
| | Educational Measurement | 2 | 2015 | 5 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2001 | 6 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2001 | 3 | 0.050 |
Why?
| | Safety | 2 | 1998 | 14 | 0.050 |
Why?
| | Forecasting | 2 | 1998 | 24 | 0.050 |
Why?
| | Curriculum | 2 | 2015 | 22 | 0.050 |
Why?
| | Health Status | 1 | 2021 | 25 | 0.050 |
Why?
| | Logistic Models | 2 | 2013 | 85 | 0.050 |
Why?
| | Virus Diseases | 1 | 2001 | 16 | 0.050 |
Why?
| | Hypertension | 2 | 1998 | 65 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2001 | 85 | 0.050 |
Why?
| | American Heart Association | 1 | 2020 | 1 | 0.050 |
Why?
| | Transitional Care | 1 | 2020 | 3 | 0.050 |
Why?
| | Checklist | 1 | 2020 | 5 | 0.050 |
Why?
| | Oximetry | 1 | 2020 | 9 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2020 | 7 | 0.050 |
Why?
| | Accelerometry | 1 | 2020 | 46 | 0.050 |
Why?
| | Infant, Newborn, Diseases | 1 | 2000 | 30 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 12 | 0.040 |
Why?
| | Patient Discharge | 1 | 2020 | 61 | 0.040 |
Why?
| | Graft Survival | 2 | 1998 | 33 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2019 | 45 | 0.040 |
Why?
| | Phenotype | 1 | 2020 | 256 | 0.040 |
Why?
| | Registries | 2 | 2013 | 93 | 0.040 |
Why?
| | Compassionate Use Trials | 1 | 2018 | 1 | 0.040 |
Why?
| | Dobutamine | 1 | 1998 | 1 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 5 | 0.040 |
Why?
| | Angioplasty, Balloon | 1 | 1998 | 7 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 1998 | 47 | 0.040 |
Why?
| | Linear Models | 1 | 1998 | 57 | 0.040 |
Why?
| | Hospitals, University | 1 | 2018 | 3 | 0.040 |
Why?
| | Videotape Recording | 1 | 1998 | 3 | 0.040 |
Why?
| | Recurrence | 1 | 1998 | 121 | 0.040 |
Why?
| | Pericardium | 1 | 1997 | 6 | 0.040 |
Why?
| | Cohort Studies | 1 | 2018 | 281 | 0.040 |
Why?
| | Troponin I | 1 | 2016 | 3 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2016 | 12 | 0.040 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2016 | 6 | 0.040 |
Why?
| | Survivors | 1 | 2016 | 17 | 0.040 |
Why?
| | Boston | 1 | 2016 | 1 | 0.040 |
Why?
| | Manometry | 1 | 2016 | 2 | 0.040 |
Why?
| | Blood Volume | 1 | 2016 | 4 | 0.040 |
Why?
| | Sodium Chloride | 1 | 2016 | 5 | 0.040 |
Why?
| | Causality | 1 | 2016 | 10 | 0.040 |
Why?
| | Reference Standards | 1 | 2016 | 15 | 0.040 |
Why?
| | North America | 1 | 2016 | 43 | 0.040 |
Why?
| | Missouri | 1 | 2016 | 77 | 0.030 |
Why?
| | Life Tables | 1 | 1995 | 2 | 0.030 |
Why?
| | Survival Analysis | 2 | 2007 | 50 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 17 | 0.030 |
Why?
| | Reference Values | 1 | 2015 | 43 | 0.030 |
Why?
| | Teaching | 1 | 2015 | 1 | 0.030 |
Why?
| | Fetal Heart | 1 | 2015 | 2 | 0.030 |
Why?
| | Competency-Based Education | 1 | 2015 | 5 | 0.030 |
Why?
| | Down Syndrome | 1 | 1995 | 39 | 0.030 |
Why?
| | Goals | 1 | 2015 | 6 | 0.030 |
Why?
| | Embryonic and Fetal Development | 1 | 1994 | 6 | 0.030 |
Why?
| | ROC Curve | 1 | 2013 | 21 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 186 | 0.030 |
Why?
| | Atenolol | 1 | 2013 | 1 | 0.030 |
Why?
| | Losartan | 1 | 2013 | 1 | 0.030 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 1 | 0.030 |
Why?
| | Technology Assessment, Biomedical | 1 | 2013 | 1 | 0.030 |
Why?
| | Bioengineering | 1 | 2013 | 1 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 6 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2013 | 4 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2013 | 5 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2013 | 25 | 0.030 |
Why?
| | Research | 1 | 2013 | 12 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 2013 | 6 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2013 | 18 | 0.030 |
Why?
| | Software | 1 | 2013 | 26 | 0.030 |
Why?
| | Blalock-Taussig Procedure | 1 | 2012 | 1 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2011 | 6 | 0.030 |
Why?
| | Transplantation, Homologous | 2 | 2004 | 21 | 0.020 |
Why?
| | Postoperative Period | 1 | 2010 | 18 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2011 | 31 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 77 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 2010 | 14 | 0.020 |
Why?
| | Amniocentesis | 1 | 2009 | 1 | 0.020 |
Why?
| | Maternal Age | 1 | 2009 | 2 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 14 | 0.020 |
Why?
| | Retinol-Binding Proteins | 1 | 1989 | 1 | 0.020 |
Why?
| | Vitamin A Deficiency | 1 | 1989 | 1 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 51 | 0.020 |
Why?
| | Fetal Blood | 1 | 1989 | 5 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 1989 | 6 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2008 | 1 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2008 | 6 | 0.020 |
Why?
| | Tachycardia | 1 | 2008 | 3 | 0.020 |
Why?
| | Monitoring, Intraoperative | 1 | 2007 | 2 | 0.020 |
Why?
| | Models, Cardiovascular | 1 | 2007 | 5 | 0.020 |
Why?
| | Models, Statistical | 1 | 2007 | 29 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2005 | 3 | 0.020 |
Why?
| | Vascular Resistance | 1 | 2005 | 4 | 0.020 |
Why?
| | Aortic Valve Stenosis | 1 | 2005 | 3 | 0.020 |
Why?
| | Fetus | 1 | 2005 | 19 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2005 | 61 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2004 | 7 | 0.020 |
Why?
| | Hemodynamics | 1 | 2004 | 16 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2004 | 16 | 0.010 |
Why?
| | Canada | 1 | 2004 | 34 | 0.010 |
Why?
| | Animals | 1 | 2005 | 741 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2001 | 19 | 0.010 |
Why?
| | Airway Obstruction | 1 | 2001 | 16 | 0.010 |
Why?
| | Magnetic Resonance Angiography | 1 | 2001 | 9 | 0.010 |
Why?
| | Infant, Premature | 1 | 2001 | 86 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 1998 | 1 | 0.010 |
Why?
| | Cause of Death | 1 | 1998 | 13 | 0.010 |
Why?
| | Coronary Angiography | 1 | 1998 | 9 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1997 | 4 | 0.010 |
Why?
| | Surgical Flaps | 1 | 1997 | 9 | 0.010 |
Why?
| | Cryopreservation | 1 | 1996 | 5 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|